These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26168257)

  • 21. Nanotoxicity assessment in plants: an updated overview.
    Zafar H; Javed R; Zia M
    Environ Sci Pollut Res Int; 2023 Sep; 30(41):93323-93344. PubMed ID: 37544947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotoxicology: the molecular science point of view.
    Pumera M
    Chem Asian J; 2011 Feb; 6(2):340-8. PubMed ID: 20725923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ingested engineered nanomaterials: state of science in nanotoxicity testing and future research needs.
    Sohal IS; O'Fallon KS; Gaines P; Demokritou P; Bello D
    Part Fibre Toxicol; 2018 Jul; 15(1):29. PubMed ID: 29970114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health hazards associated with nanomaterials.
    Pattan G; Kaul G
    Toxicol Ind Health; 2014 Jul; 30(6):499-519. PubMed ID: 23012342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of engineered nanomaterials mediated by nano-bio-eco interactions.
    He X; Fu P; Aker WG; Hwang HM
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018 Jan; 36(1):21-42. PubMed ID: 29297743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge gaps between nanotoxicological research and nanomaterial safety.
    Hu X; Li D; Gao Y; Mu L; Zhou Q
    Environ Int; 2016 Sep; 94():8-23. PubMed ID: 27203780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of metabolomics and transcriptomics in nanotoxicity studies.
    Shin TH; Lee DY; Lee HS; Park HJ; Jin MS; Paik MJ; Manavalan B; Mo JS; Lee G
    BMB Rep; 2018 Jan; 51(1):14-20. PubMed ID: 29301609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical properties of nanomaterials: implication in associated toxic manifestations.
    Gatoo MA; Naseem S; Arfat MY; Dar AM; Qasim K; Zubair S
    Biomed Res Int; 2014; 2014():498420. PubMed ID: 25165707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic approach to nanotoxicity.
    Matysiak M; Kapka-Skrzypczak L; Brzóska K; Gutleb AC; Kruszewski M
    J Proteomics; 2016 Mar; 137():35-44. PubMed ID: 26506535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular toxicity of nanomaterials.
    Chang XL; Yang ST; Xing G
    J Biomed Nanotechnol; 2014 Oct; 10(10):2828-51. PubMed ID: 25992420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intelligent testing strategy and analytical techniques for the safety assessment of nanomaterials.
    Chen R; Qiao J; Bai R; Zhao Y; Chen C
    Anal Bioanal Chem; 2018 Sep; 410(24):6051-6066. PubMed ID: 29550875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity Assessment in the Nanoparticle Era.
    De Matteis V; Rinaldi R
    Adv Exp Med Biol; 2018; 1048():1-19. PubMed ID: 29453529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomaterials meet zebrafish: Toxicity evaluation and drug delivery applications.
    Jia HR; Zhu YX; Duan QY; Chen Z; Wu FG
    J Control Release; 2019 Oct; 311-312():301-318. PubMed ID: 31446084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling.
    Lubinski L; Urbaszek P; Gajewicz A; Cronin MT; Enoch SJ; Madden JC; Leszczynska D; Leszczynski J; Puzyn T
    SAR QSAR Environ Res; 2013; 24(12):995-1008. PubMed ID: 24313439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnology for in vitro neuroscience.
    Cooper DR; Nadeau JL
    Nanoscale; 2009 Nov; 1(2):183-200. PubMed ID: 20644838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicology of nanomaterials used in nanomedicine.
    Zhao J; Castranova V
    J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward the development of "nano-QSARs": advances and challenges.
    Puzyn T; Leszczynska D; Leszczynski J
    Small; 2009 Nov; 5(22):2494-509. PubMed ID: 19787675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotoxicology: toxicity and biological effects of nanoparticles for new evaluation standards.
    Lee SB
    Nanomedicine (Lond); 2011 Jul; 6(5):759-61. PubMed ID: 21793669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.